Publications by authors named "Davide Bonanni"

Claim this Profile
S
Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer.
Andrea Citarella, Silvia Belluti, Davide Bonanni, Davide Moi, Isabella Piccinini

J Med Chem· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer.
Davide Moi, Davide Bonanni, Silvia Belluti, Pasquale Linciano, Andrea Citarella

Eur J Med Chem· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of machine learning classifiers to predict compound activity on prostate cancer cell lines.
Davide Bonanni, Luca Pinzi, Giulio Rastelli

J Cheminform· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-]pyridine Scaffold: SAR of the Aryloxyaryl Moiety.
Stefano Sainas, Marta Giorgis, Paola Circosta, Giulio Poli, Marta Alberti, Davide Bonanni

J Med Chem· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Targeting Strategies on Histone Deacetylase 6 (HDAC6) and Heat Shock Protein 90 (Hsp90).
Davide Bonanni, Andrea Citarella, Davide Moi, Luca Pinzi, Elisa Bergamini

Curr Med Chem· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ring.
Davide Moi, Andrea Citarella, Davide Bonanni, Luca Pinzi, Daniele Passarella

RSC Adv· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications.
Andrea Citarella, Davide Moi, Luca Pinzi, Davide Bonanni, Giulio Rastelli

ACS Omega· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-]pyridine Scaffold: SAR of the Biphenyl Moiety.
Stefano Sainas, Marta Giorgis, Paola Circosta, Valentina Gaidano, Davide Bonanni

J Med Chem· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational Method for Structure-Based Analysis of SAR Transfer.
Davide Bonanni, Marco L Lolli, Jürgen Bajorath

J Med Chem· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of [2 + 2 + 2] cyclotrimerisation methodology to prepare tetrahydroisoquinoline-based compounds with potential aldo-keto reductase 1C3 target affinity.
Ana R N Santos, Helen M Sheldrake, Ali I M Ibrahim, Chhanda Charan Danta, Davide Bonanni

Medchemcomm· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3.
Marco L Lolli, Irene M Carnovale, Agnese C Pippione, Weixiao Y Wahlgren, Davide Bonanni

ACS Med Chem Lett· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors.
Stefano Sainas, Agnese C Pippione, Elisa Lupino, Marta Giorgis, Paola Circosta, Davide Bonanni

J Med Chem· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors.
Stefano Sainas, Agnese C Pippione, Elisa Lupino, Marta Giorgis, Paola Circosta, Davide Bonanni

J Med Chem· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents.
Laurent R Chiarelli, Matteo Mori, Daniela Barlocco, Giangiacomo Beretta, Arianna Gelain, Davide Bonanni

Eur J Med Chem· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid.
Agnese Chiara Pippione, Irene Maria Carnovale, Davide Bonanni, Marcella Sini, Parveen Goyal

Eur J Med Chem· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxytriazole derivatives as potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors discovered by bioisosteric scaffold hopping approach.
Agnese C Pippione, Alessandro Giraudo, Davide Bonanni, Irene M Carnovale, Elisabetta Marini

Eur J Med Chem· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis